logo

For the Inventor, By the Inventor

Baden, Austria

Ulrike Tontsch-Grunt

USPTO Granted Patents = 11 

 

Average Co-Inventor Count = 7.2

ph-index = 6

Forward Citations = 128(Granted Patents)


Company Filing History:

goldMedal6 out of 194 
 
Boehringer Ingelheim Pharma Gmbh & Co Kg
 patents
silverMedal3 out of 1,537 
 
Boehringer Ingelheim International Gmbh
 patents
bronzeMedal2 out of 149 
 
Boehringer Ingelheim Pharma Kg
 patents

Years Active: 2004-2014

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents
1. 8623887 - Compounds (2014-01-07),
2. 8207179 - Substituted indolines as tyrosine kinase inhibitors (2012-06-26),
3. 7981880 - 3-(aminomethyliden) 2-indolinone derivates and their use as cell proliferation inhibitors (2011-07-19),
4. 7858616 - Indolinone derivatives substituted in the 6 position, their preparation and their use as medicaments (2010-12-28),
5. 7547703 - Indoline derivatives substituted in the 6-position, their preparation and their use as medicaments (2009-06-16),
6. 7514468 - Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions (2009-04-07),
7. 7169936 - Indolinone derivatives substituted in the 6-position, their preparation and their use as medicaments (2007-01-30),
8. 7148249 - Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments (2006-12-12),
9. 6855710 - Substituted indolines with an inhibitory effect on various kinases and complexes of CDKs (2005-02-15),
10. 6794395 - Substituted indolinones, their manufacture and their use as medicaments (2004-09-21),
11. 6762180 - Substituted indolines which inhibit receptor tyrosine kinases (2004-07-13),

Title: Trailblazer in Inventions: The Innovative Journey of Ulrike Tontsch-Grunt

Introduction: Ulrike Tontsch-Grunt, a distinguished inventor hailing from Baden, Austria, has left an indelible mark in the realm of technological advancements with his relentless pursuit of excellence and dedication to innovation.

Latest Patents: With a notable portfolio of 11 patents, Ulrike Tontsch-Grunt's latest inventions focus on compounds that serve as tyrosine kinase inhibitors, holding immense promise for the treatment of diseases characterized by abnormal cell proliferation.

Career Highlights: Having contributed significantly to the field of inventions, Ulrike Tontsch-Grunt has lent his expertise to renowned companies such as Boehringer Ingelheim Pharma GmbH & Co. KG and Boehringer Ingelheim International GmbH, where his innovative spirit thrived.

Collaborations: Throughout his illustrious career, Ulrike Tontsch-Grunt has collaborated with esteemed colleagues such as Gerald Juergen Roth and Armin Heckel, fostering a culture of innovation and pushing the boundaries of technological evolution.

Conclusion: Ulrike Tontsch-Grunt's visionary approach to inventions, coupled with his passion for pushing the boundaries of technological innovation, cements his status as a trailblazer in the world of inventions, inspiring generations of inventors to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…